NCT02879123

Brief Summary

This trial aims at collecting standardized data concerning the early neurological clinical recovery of patients, 3 months after endovascular treatment of an acute ischemic stroke. Although this outcome is a major issue of patients' prognosis, it is rarely collected at this stage of their follow-up.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
61mo left

Started Nov 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Nov 2015May 2031

Study Start

First participant enrolled

November 12, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 22, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 25, 2016

Completed
14.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2030

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2031

Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

15 years

First QC Date

August 22, 2016

Last Update Submit

January 21, 2026

Conditions

Stroke, Acute

Outcome Measures

Primary Outcomes (1)

  • early neurological clinical recovery

    modified RANKIN score

    3 months after endovascular treatment of an acute ischemic stroke

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients undergoing endovascular treatment for an acute ischemic stroke

You may qualify if:

  • acute ischemic stroke
  • endovascular treatment

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ophtalmologique Adolphe de Rothschild

Paris, 75019, France

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Raphaël Blanc, MD

    Fondation Ophtalmologique Adolphe de Rothschild

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Raphaël Blanc, MD

CONTACT

+ 33 01 48 03 68 28rblanc@for.paris

Amélie Yavchitz, MD

CONTACT

+33 01 48 03 64 54ayavchitz@for.paris

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2016

First Posted

August 25, 2016

Study Start

November 12, 2015

Primary Completion (Estimated)

November 12, 2030

Study Completion (Estimated)

May 12, 2031

Last Updated

January 22, 2026

Record last verified: 2026-01

Locations

FR(1)